NOVO-DIPIRADOL TAB 75MG 75 MG
DIPYRIDAMOLE : 75 MG · DIN 00784435 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-DIPIRADOL TAB 75MG?
NOVO-DIPIRADOL TAB 75MG 75 MG contains DIPYRIDAMOLE : 75 MG. It is listed in the Health Canada Drug Product Database under DIN 00784435, held by NOVOPHARM LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00784435 |
|---|---|
| Brand name | NOVO-DIPIRADOL TAB 75MG |
| Generic / active ingredient | DIPYRIDAMOLE : 75 MG |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 75 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B01AC07 DIPYRIDAMOLE |
| AHFS class | 24:12.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Aug-2005 |
| Original market date | 1989-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B01AC07 DIPYRIDAMOLE. 2 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIPYRIDAMOLE INJECTION, USP | 5 MG | LIQUID | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02244475 |
| PERSANTINE | 5 MG | SOLUTION | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | MARKETED | DIN 00637734 |
| APO-DIPYRIDAMOLE | 100 MG | TABLET | APOTEX INC | CANCELLED PRE MARKET | DIN 02220571 |
| APO-DIPYRIDAMOLE | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895644 |
| APO-DIPYRIDAMOLE | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895652 |
| APO-DIPYRIDAMOLE | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895660 |
| APO-DIPYRIDAMOLE-SC TAB 25MG | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571237 |
| APO-DIPYRIDAMOLE-SC TAB 50MG | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571245 |
| APO-DIPYRIDAMOLE-SC TAB 75MG | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00601845 |
| DIPYRIDAMOLE 25 TAB 25MG | 25 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00579580 |
Who else supplies DIPYRIDAMOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIPYRIDAMOLE appears in 15 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.